vTv Therapeutics (VTVT) Reports In-Line Q3 EPS
vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.